JuliaHub has doubled its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform.

This latest release introduces advanced capabilities that further streamline workflows, improve compliance, and drive innovation across pharmacometrics, modeling, and analytics. With this update, JuliaHub continues to redefine efficiency and impact in pharmaceutical innovation, supporting organizations from preclinical research to regulatory submissions.

JuliaHub simplifies complex pharmaceutical workflows by integrating analytics such as modeling and simulation in pharmacometrics. Unlike fragmented systems, it ensures seamless transitions between stages, boosting efficiency and collaboration. JuliaHub's capabilities are further strengthened by its strong partnership with Pumas-AI, a joint venture company with JuliaHub since 2019.

Deepak Vinchhi, Co-founder and COO of JuliaHub, emphasized,” Our collaboration with Pumas-AI brings an unparalleled advantage in pharmaceutical development. By integrating advanced pharmacometric modeling with JuliaHub's scalable, high-performance platform, we empower teams to achieve faster, more reliable outcomes – accelerating the delivery of life-saving treatments to patients. This partnership reflects a shared vision: to advance drug development through innovative, scalable, and compliant solutions that drive efficiency, accuracy, and groundbreaking discoveries across every stage of the pharmaceutical lifecycle."

JuliaHub Board Member and ex-CEO of Snowflake, Bob Muglia, highlighted, "The JuliaHub platform provides a suite of tools and features for pharma customers to effortlessly carry out analyses at each stage of the drug development process – supporting pre-clinical, clinical, post-marketing as well as regulatory submissions. Features such as Time Capsule greatly reduce the effort to meet regulatory requirements, making it faster and easier to bring new products to market and leading to tremendous savings in time and money. We are heavily investing in JuliaHub to establish it as a best-in-class solution for the pharmaceutical industry."

Vijay Ivaturi, CEO of Pumas-AI, talked about JuliaHub’s impact on pharmaceutical development, saying, "Pumas-AI has successfully developed and submitted 26 drugs to the FDA using JuliaHub’s powerful platform. The scalability, performance, and compliance capabilities of JuliaHub have played a pivotal role in ensuring seamless drug development and regulatory success. JuliaHub is setting a new standard for efficiency and innovation in the pharmaceutical industry."

JuliaHub seamlessly integrates with industry-standard tools such as Pumas, RStudio, SAS, Nonmem, Monolix, and Phoenix, ensuring pharmaceutical teams can adopt the platform without disrupting existing workflows. It fosters collaboration through shared workspaces, built-in version control, and granular access controls while maintaining full regulatory compliance.

Features like Time Capsule support traceability by retaining job information for years, and detailed audit logs enhance transparency and adherence to FDA 21 CFR Part-11 regulations, making regulatory submissions faster and more efficient.